Allworth Financial’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4K | Hold |
3,642
| – | – | ﹤0.01% | 2565 |
|
|
2025
Q1 | $22.9K | Sell |
3,642
-267
| -7% | -$1.68K | ﹤0.01% | 1991 |
|
|
2024
Q4 | $41.2K | Buy |
3,909
+267
| +7% | +$2.81K | ﹤0.01% | 1670 |
|
|
2024
Q3 | $27.3K | Sell |
3,642
-106
| -3% | -$794 | ﹤0.01% | 1716 |
|
|
2024
Q2 | $37.6K | Sell |
3,748
-221
| -6% | -$2.22K | ﹤0.01% | 1512 |
|
|
2024
Q1 | $40.2K | Sell |
3,969
-42
| -1% | -$425 | ﹤0.01% | 1391 |
|
|
2023
Q4 | $40.4K | Buy |
4,011
+188
| +5% | +$1.89K | ﹤0.01% | 1279 |
|
|
2023
Q3 | $35.8K | Buy |
3,823
+1
| +0% | +$9 | ﹤0.01% | 1242 |
|
|
2023
Q2 | $93.8K | Sell |
3,822
-688
| -15% | -$16.9K | ﹤0.01% | 917 |
|
|
2023
Q1 | $105K | Sell |
4,510
-711
| -14% | -$16.5K | ﹤0.01% | 839 |
|
|
2022
Q4 | $132K | Buy |
5,221
+3
| +0.1% | +$76 | ﹤0.01% | 734 |
|
|
2022
Q3 | $101K | Buy |
5,218
+97
| +2% | +$1.88K | ﹤0.01% | 768 |
|
|
2022
Q2 | $130K | Buy |
5,121
+21
| +0.4% | +$533 | ﹤0.01% | 651 |
|
|
2022
Q1 | $131K | Buy |
5,100
+4,916
| +2,672% | +$126K | ﹤0.01% | 656 |
|
|
2021
Q4 | $8K | Buy |
+184
| New | +$8K | ﹤0.01% | 1484 |
|
|
2021
Q2 | – | Sell |
-65
| Closed | -$3K | – | 1672 |
|
|
2021
Q1 | $3K | Buy |
+65
| New | +$3K | ﹤0.01% | 1254 |
|